Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6371)
All Articles published online
|
Publishing Process of This Article
|
Feb 12, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Virology
ISSN
2220-3249
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Coppola N, Martini S, Pisaturo M, Sagnelli C, Filippini P, Sagnelli E. Treatment of chronic hepatitis C in patients with HIV/HCV coinfection. World J Virology 2015; 4(1): 1-12 [PMID: 25674512 DOI: 10.5501/wjv.v4.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v4/i1/1.htm |
| Number | Citing Articles |
| 1 |
I. P. Balmasova, M. S. Aristanbekova, E. S. Malova, R. I. Sepiashvili. MECHANISMS OF INTERACTION OF VIRAL CAUSATIVE AGENTS IN PATIENTS CO-INFECTED WITH HUMAN IMMUNODEFICIENCY AND HEPATITIS C VIRUSES. Journal of microbiology, epidemiology and immunobiology 2016; 93(5): 101 doi: 10.36233/0372-9311-2016-5-101-109
|
| 2 |
Fatih Ermis, Elif Senocak Tasci. New treatment strategies for hepatitis C infection. World Journal of Hepatology 2015; 7(17): 2100-2109 doi: 10.4254/wjh.v7.i17.2100
|
| 3 |
Prarthana Thiagarajan, Stephen D. Ryder. The hepatitis C revolution part 2. Current Opinion in Infectious Diseases 2015; 28(6): 572 doi: 10.1097/QCO.0000000000000204
|
| 4 |
Robert W. Buckheit, R. Dwayne Lunsford. Antimicrobial Drug Resistance. 2017; : 1329 doi: 10.1007/978-3-319-47266-9_31
|
| 5 |
Sten Westgard, Danijela Lucic. Sigma Metrics for Assessing Accuracy of Molecular Testing. Clinical Microbiology Newsletter 2015; 37(13): 103 doi: 10.1016/j.clinmicnews.2015.06.001
|
| 6 |
Caterina Sagnelli, Salvatore Martini, Mariantonietta Pisaturo, Giuseppe Pasquale, Margherita Macera, Rosa Zampino, Nicola Coppola, Evangelista Sagnelli. Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact. World Journal of Hepatology 2015; 7(24): 2510-2521 doi: 10.4254/wjh.v7.i24.2510
|
| 7 |
Jia‐Wu Zhu, Feng‐Liang Liu, Dan Mu, De‐Yao Deng, Yong‐Tang Zheng. Increased expression and dysregulated association of restriction factors and type I interferon in HIV, HCV mono‐ and co‐infected patients. Journal of Medical Virology 2016; 88(6): 987 doi: 10.1002/jmv.24419
|
| 8 |
Isabella Esposito, Pablo Labarga, Pablo Barreiro, José V Fernandez-Montero, Carmen de Mendoza, Laura Benítez-Gutiérrez, José M Peña, Vicente Soriano. Dual antiviral therapy for HIV and hepatitis C – drug interactions and side effects. Expert Opinion on Drug Safety 2015; 14(9): 1421 doi: 10.1517/14740338.2015.1073258
|
| 9 |
Evangelista Sagnelli, Mario Starace, Carmine Minichini, Mariantonietta Pisaturo, Margherita Macera, Caterina Sagnelli, Nicola Coppola. Resistance detection and re-treatment options in hepatitis C virus-related chronic liver diseases after DAA-treatment failure. Infection 2018; 46(6): 761 doi: 10.1007/s15010-018-1188-3
|
| 10 |
Luciani F. New Scenarios in the Treatment of HIV/HCV Co-Infection. Journal of Human Virology & Retrovirology 2015; 2(4) doi: 10.15406/jhvrv.2015.02.00049
|
| 11 |
Н.В. Матиевская, О.А. Хомбак, С.С. Писарь. Influence of Directly Acting Antiviral Therapy of Hepatitis C on the Course of HIV Infection in Patients with HIV and HCV co-Infection. Клиническая инфектология и паразитология 2020; (2): 192 doi: 10.34883/PI.2020.9.2.004
|
| 12 |
Rachel Presti, Giuseppe Pantaleo. Infectious Diseases. 2017; : 837 doi: 10.1016/B978-0-7020-6285-8.00092-7
|
| 13 |
Ivan Gentile, Alberto Enrico Maraolo, Antonio Riccardo Buonomo, Emanuela Zappulo, Guglielmo Borgia. The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C. Expert Opinion on Drug Discovery 2015; 10(12): 1363 doi: 10.1517/17460441.2015.1094051
|
| 14 |
Nunzia Sanarico, Stefania D’Amato, Roberto Bruni, Claudia Rovetto, Emanuela Salvi, Patrizia Di Zeo, Paola Chionne, Elisabetta Madonna, Giulio Pisani, Angela Costantino, Michele Equestre, Maria E. Tosti, Alessandra Cenci, Maria T. Maggiorella, Leonardo Sernicola, Emanuele Pontali, Alfredo Pansera, Rocco Quattrocchi, Sergio Carbonara, Fabio Signorile, Lorenzo Antonio Surace, Guido Federzoni, Elisa Garlassi, Giulio Starnini, Roberto Monarca, Sergio Babudieri, Maria Rapicetta, Maria G. Pompa, Anna Caraglia, Barbara Ensoli, Anna R. Ciccaglione, Stefano Buttò. Correlates of infection and molecular characterization of blood-borne HIV, HCV, and HBV infections in HIV-1 infected inmates in Italy. Medicine 2016; 95(44): e5257 doi: 10.1097/MD.0000000000005257
|
| 15 |
Nicola Coppola, Mariantonietta Pisaturo, Rosa Zampino, Margherita Macera, Caterina Sagnelli, Evangelista Sagnelli. Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals. World Journal of Gastroenterology 2015; 21(38): 10749-10759 doi: 10.3748/wjg.v21.i38.10749
|
| 16 |
Stefania Farcomeni, Sonia Moretti, Caterina Fimiani, Lucia Fontanelli Sulekova, Fenicia Vescio, Leonardo Sernicola, Maria T. Maggiorella, Anna Lisa Remoli, Orietta Picconi, Luciana Mosca, Rozenn Esvan, Elisa Biliotti, Massimo Ciccozzi, Marco Sgarbanti, Gloria Taliani, Alessandra Borsetti. Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy. Pathogens 2021; 10(11): 1488 doi: 10.3390/pathogens10111488
|
| 17 |
Harita Nyalakonda, Netanya S. Utay. A new era of therapy for hepatitis C virus infection. Current Opinion in Infectious Diseases 2015; 28(5): 471 doi: 10.1097/QCO.0000000000000190
|
| 18 |
Natalie N. Whitfield, Donna M. Wolk. Clinical Virology Manual. 2016; : 145 doi: 10.1128/9781555819156.ch13
|
| 19 |
Vicente Soriano, Pablo Labarga, José V. Fernandez-Montero, Carmen de Mendoza, Laura Benítez-Gutiérrez, José M. Peña, Pablo Barreiro. Drug interactions in HIV-infected patients treated for hepatitis C. Expert Opinion on Drug Metabolism & Toxicology 2017; 13(8): 807 doi: 10.1080/17425255.2017.1351942
|
| 20 |
APASL consensus statements and recommendation on treatment of hepatitis C. Hepatology International 2016; 10(5): 702 doi: 10.1007/s12072-016-9717-6
|
| 21 |
David Whiteley, Anne Whittaker, Lawrie Elliott, Sarah Cunningham-Burley. The lived experience of interferon-free treatments for hepatitis C: A thematic analysis. International Journal of Drug Policy 2016; 38: 21 doi: 10.1016/j.drugpo.2016.10.013
|